Apellis Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/30/2026 | 650 | 0.0% | 25,863 | 12/31/2025 |
| 2024 Q3 | 11/4/2024 | 1,436 | 0.0% | 49,795 | 9/30/2024 |
| 2024 Q2 | 8/7/2024 | 1,735 | 0.0% | 45,241 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 2,494 | 0.0% | 42,421 | 3/31/2024 |
| 2023 Q4 | 2/2/2024 | 3,176 | 0.0% | 53,064 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 2,340 | 0.0% | 61,521 | 9/30/2023 |
| 2023 Q2 | 8/2/2023 | 4,664 | 0.0% | 51,193 | 6/30/2023 |
| 2023 Q1 | 4/26/2023 | 3,634 | 0.0% | 55,095 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 2,994 | 0.0% | 57,903 | 12/31/2022 |
| 2022 Q3 | 10/28/2022 | 3,745 | 0.0% | 54,834 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 2,299 | 0.0% | 50,843 | 6/30/2022 |
| 2022 Q1 | 5/3/2022 | 3,009 | 0.0% | 59,226 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 3,023 | 0.0% | 63,934 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 1,440 | 0.0% | 43,684 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 3,062 | 0.0% | 48,457 | 6/30/2021 |
| 2021 Q1 | 4/27/2021 | 2,161 | 0.0% | 50,359 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 3,624 | 0.0% | 63,352 | 12/31/2020 |
| 2020 Q3 | 10/27/2020 | 2,511 | 0.0% | 83,240 | 9/30/2020 |
| 2020 Q2 | 8/4/2020 | 1,978 | 0.0% | 60,570 | 6/30/2020 |
| 2020 Q1 | 6/19/2020 | 2,082 | 0.0% | 77,703 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 2,379 | 0.0% | 77,703 | 12/31/2019 |